| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 0.95× | 0.95× | 0.94× | — | 0.70× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.10× | 0.10× | 0.10× | 0.09× | 0.09× | ||
| — | — | — | −3.70× | — | ||
| — | — | — | −1.07× | — |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 0.70 | — | 0.94 | 0.95 | 0.95 | |
| Asset Turnover | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | |
| Cash Conversion (CFO/Net Income) | — | -3.70 | — | — | — | |
| CFO/EBITDA | — | -1.07 | — | — | — |